T-cells in the Cerebrospinal Fluid Express a Similar Repertoire of Inflammatory Chemokine Receptors in the Absence or Presence of CNS Inflammation: Implications for CNS Trafficking

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2002 Aug 29

PMID 12197893

Citations 55

Authors

P Kivisakk

C Trebst

Z Liu

B H Tucky

T L Sorensen

R A Rudick

M Mack

R M Ransohoff

Affiliations

Soon will be listed here.

Abstract

It is believed that chemokines and their receptors are involved in trafficking of T-cells to the central nervous system (CNS). The aim of the current study was to define the expression on cerebrospinal fluid (CSF) T-cells of six chemokine receptors associated with trafficking to sites of inflammation. Flow cytometry was used to detect chemokine receptor expression. We observed that CD3+T-cells in the CSF express a restricted array of inflammatory chemokine receptors, specifically CXCR3, CCR5 and CCR6, but little CCR1-3. This repertoire was independent of the presence of CNS inflammation, since comparable findings were obtained in patients with multiple sclerosis (MS) and individuals with non-inflammatory neurological diseases. The enrichment of CCR5+T-cells in the CSF could largely be explained by higher frequency of CD4+/CD45RO+T-cells in this compartment. In contrast, CD4+/CD45RO+T-cells expressing CXCR3 were significantly enriched in CSF as compared with blood. Similar levels of CCR6+/CD3+T-cells were observed in blood and CSF, while levels of CCR2+/CD3+T-cells were lower in CSF than in blood. The CSF was virtually devoid of CCR5+/CXCR3- T-cells, suggesting that the expression of CCR5 alone is not sufficient for the trafficking of CD3+T-cells to the CSF. We hypothesize that CXCR3 is the principal inflammatory chemokine receptor involved in intrathecal accumulation of T-cells in MS. Through interactions with its ligands, CXCR3 is proposed to mediate retention of T-cells in the inflamed CNS.

Citing Articles

Pediatric cerebrospinal fluid immune profiling distinguishes pediatric-onset multiple sclerosis from other pediatric-onset acute neurological disorders.

Espinoza D, Zrzavy T, Breville G, Thebault S, Marefi A, Mexhitaj I bioRxiv. 2025; .

PMID: 40060552 PMC: 11888486. DOI: 10.1101/2025.02.27.637541.

Causal associations between gut microbiota, circulating inflammatory proteins, and epilepsy: a multivariable Mendelian randomization study.

Yang H, Liu W, Gao T, Liu Q, Zhang M, Liu Y Front Immunol. 2024; 15:1438645.

PMID: 39315097 PMC: 11416947. DOI: 10.3389/fimmu.2024.1438645.

Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy.

Waede M, Voss L, Kingo C, Moeller J, Elkjaer M, Illes Z Ann Clin Transl Neurol. 2024; 11(10):2657-2672.

PMID: 39279291 PMC: 11514931. DOI: 10.1002/acn3.52182.

The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis.

Angelini G, Bani A, Constantin G, Rossi B Front Cell Neurosci. 2023; 17:1101379.

PMID: 36874213 PMC: 9975172. DOI: 10.3389/fncel.2023.1101379.

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M Proc Natl Acad Sci U S A. 2023; 120(3):e2207291120.

PMID: 36634138 PMC: 9934304. DOI: 10.1073/pnas.2207291120.

References

Shields P, Morland C, Salmon M, Qin S, Hubscher S, Adams D . Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 1999; 163(11):6236-43. View

Liao F, Rabin R, Smith C, Sharma G, Nutman T, Farber J . CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol. 1999; 162(1):186-94. View

Traynor T, Kuziel W, Toews G, Huffnagle G . CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol. 2000; 164(4):2021-7. DOI: 10.4049/jimmunol.164.4.2021. View

Murphy P, Baggiolini M, Charo I, Hebert C, Horuk R, Matsushima K . International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000; 52(1):145-76. View

Zlotnik A, Yoshie O . Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12(2):121-7. DOI: 10.1016/s1074-7613(00)80165-x. View

Campbell J, Butcher E . Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000; 12(3):336-41. DOI: 10.1016/s0952-7915(00)00096-0. View

Simpson J, Newcombe J, Cuzner M, Woodroofe M . Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2000; 26(2):133-42. DOI: 10.1046/j.1365-2990.2000.026002133.x. View

Carrithers M, Visintin I, Kang S, Janeway Jr C . Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain. 2000; 123 ( Pt 6):1092-101. DOI: 10.1093/brain/123.6.1092. View

Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F . Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000; 96(1):41-9. View

10.

Sorensen T, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik V . Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999; 103(6):807-15. PMC: 408141. DOI: 10.1172/JCI5150. View

11.

Rabin R, Park M, Liao F, Swofford R, Stephany D, Farber J . Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol. 1999; 162(7):3840-50. View

12.

Lee B, Sharron M, Montaner L, Weissman D, Doms R . Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999; 96(9):5215-20. PMC: 21844. DOI: 10.1073/pnas.96.9.5215. View

13.

Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V . Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum. 1999; 42(5):981-8. DOI: 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4. View

14.

Balashov K, Rottman J, Weiner H, Hancock W . CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A. 1999; 96(12):6873-8. PMC: 22009. DOI: 10.1073/pnas.96.12.6873. View

15.

Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers C, Prange H . Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler. 1999; 5(3):138-46. DOI: 10.1177/135245859900500302. View

16.

Ochi H, Hirani W, Yuan Q, Friend D, Austen K, Boyce J . T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999; 190(2):267-80. PMC: 2195573. DOI: 10.1084/jem.190.2.267. View

17.

Flier J, Boorsma D, Bruynzeel D, van Beek P, Stoof T, Scheper R . The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol. 1999; 113(4):574-8. DOI: 10.1046/j.1523-1747.1999.00730.x. View

18.

Simpson J, Rezaie P, Newcombe J, Cuzner M, Male D, Woodroofe M . Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol. 2000; 108(1-2):192-200. DOI: 10.1016/s0165-5728(00)00274-5. View

19.

Sallusto F, Lanzavecchia A . Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev. 2001; 177:134-40. DOI: 10.1034/j.1600-065x.2000.17717.x. View

20.

Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N . Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol. 2001; 114(1-2):207-12. DOI: 10.1016/s0165-5728(00)00456-2. View